Fabio Piscaglia
#129,631
Most Influential Person Now
Researcher
Fabio Piscaglia's AcademicInfluence.com Rankings
Fabio Piscagliacomputer-science Degrees
Computer Science
#5642
World Rank
#5960
Historical Rank
Computational Linguistics
#840
World Rank
#853
Historical Rank
Machine Learning
#1574
World Rank
#1596
Historical Rank
Artificial Intelligence
#1804
World Rank
#1836
Historical Rank
Download Badge
Computer Science
Fabio Piscaglia's Degrees
- PhD Computer Science University of Bologna
- Masters Computer Engineering University of Bologna
- Bachelors Computer Engineering University of Bologna
Similar Degrees You Can Earn
Why Is Fabio Piscaglia Influential?
(Suggest an Edit or Addition)Fabio Piscaglia's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. (2018) (5681)
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial (2018) (2744)
- Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. (2013) (1082)
- The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. (2011) (1074)
- EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. (2013) (931)
- EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography.Part 2: Clinical Applications (2013) (852)
- Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. (2008) (792)
- The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. (2006) (693)
- Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis (2001) (673)
- EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) (2017) (654)
- The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) (2018) (565)
- Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions (2012) (554)
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. (2011) (490)
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study (2016) (449)
- Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma (2005) (441)
- Field‐practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy (2011) (351)
- Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012 (2012) (336)
- An EFSUMB Introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for Quantification of Tumour Perfusion (2012) (335)
- Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria (2008) (331)
- Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. (1999) (325)
- Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. (2013) (289)
- What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. (1997) (253)
- AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. (2017) (243)
- Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance (2004) (234)
- Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas (2011) (228)
- Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013 (2015) (222)
- EFSUMB Guidelines and Recommendations on the Clinical (2017) (221)
- Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. (2013) (214)
- The Impact of Vascular and Nonvascular Findings on the Noninvasive Diagnosis of Small Hepatocellular Carcinoma Based on the EASL and AASLD Criteria (2010) (212)
- Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. (2020) (209)
- Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression (2005) (203)
- How to perform Contrast-Enhanced Ultrasound (CEUS) (2018) (200)
- Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence (2005) (193)
- Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma (2012) (190)
- Comparison of Recurrence of Hepatocellular Carcinoma After Resection in Patients with Cirrhosis to Its Occurrence in a Surveilled Cirrhotic Population (2009) (180)
- Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. (2012) (177)
- Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair (1999) (174)
- Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. (2013) (172)
- Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. (2015) (166)
- Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. (2010) (155)
- Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: A long‐term prospective study (1999) (147)
- EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) (2017) (145)
- The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Short Version) (2018) (136)
- Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. (2004) (135)
- Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography. (2011) (131)
- Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. (2008) (127)
- CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI (2017) (125)
- Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand". (2012) (123)
- Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma (2016) (113)
- Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage (2016) (113)
- VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study (2014) (111)
- New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm (2018) (109)
- Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation (2010) (109)
- Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2020 – WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS (2020) (108)
- Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules. (2017) (106)
- High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? (2006) (106)
- Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. (2013) (104)
- EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III - Abdominal Treatment Procedures (Short Version). (2015) (103)
- EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part IV – EUS-guided Interventions: General aspects and EUS-guided sampling (Long Version) (2015) (100)
- Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound (2013) (98)
- Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. (2012) (98)
- Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR) (2017) (98)
- Impact of gadoxetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance on the non‐invasive diagnosis of small hepatocellular carcinoma: a prospective study (2013) (97)
- Nivolumab (NIVO) + ipilimumab (IPI) + cabozantinib (CABO) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040. (2020) (95)
- Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy (2011) (93)
- Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system (2017) (90)
- Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension? (2013) (89)
- American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of Hepatocellular Carcinoma: a pictorial essay (2017) (88)
- EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version). (2017) (87)
- EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part V (2015) (85)
- Expression of reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibroblasts. (2002) (85)
- Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. (2013) (85)
- Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment (2018) (85)
- Contrast enhanced ultrasound identifies hepatocellular carcinoma in cirrhosis: a large multicenter retrospective study (2017) (83)
- Phase III trial of lenvatinib (LEN) vs sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC). (2017) (82)
- Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice (2018) (82)
- Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease (2006) (81)
- Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis (2018) (81)
- EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part I – General Aspects (long Version) (2015) (81)
- The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: a retrospective multicentre study. (2013) (81)
- Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group (2018) (80)
- Characterization of liver lesions by real-time contrast-enhanced ultrasonography (2007) (80)
- New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. (2007) (79)
- Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation (2009) (78)
- Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer (2007) (78)
- Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography. (2009) (78)
- Ultrasound in portal hypertension--part 2--and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. (2012) (77)
- Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma (2016) (75)
- EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part VI – Ultrasound-Guided Vascular Interventions (2015) (74)
- High Prevalence of Helicobacter pylori in Liver Cirrhosis (Relationship with Clinical and Endoscopic Features and the Risk of Peptic Ulcer) (1997) (74)
- Characterization of focal liver lesions with contrast-enhanced ultrasound. (2010) (72)
- EFSUMB Statement on Medical Student Education in Ultrasound [long version] (2016) (72)
- EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part I – General Aspects (Short Version) (2015) (72)
- Conditional Survival after Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients (2012) (71)
- Value of splanchnic Doppler ultrasound in the diagnosis of portal hypertension. (2001) (70)
- Characterization of Primary and Recurrent Nodules in Liver Cirrhosis Using Contrast-Enhanced Ultrasound: Which Vascular Criteria Should Be Adopted? (2013) (69)
- When to perform hepatic resection for intermediate‐stage hepatocellular carcinoma (2015) (69)
- Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study (2020) (68)
- A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma (2017) (68)
- The role of ultrasound elastographic techniques in chronic liver disease: current status and future perspectives. (2014) (66)
- Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. (2010) (63)
- Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma. (2014) (62)
- Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials (2017) (62)
- EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III – Abdominal Treatment Procedures (Long Version) (2015) (60)
- Intra- and extrahepatic arterial resistances in chronic hepatitis and liver cirrhosis. (1997) (59)
- Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients. (2019) (59)
- Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma. (2015) (59)
- Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. (2016) (58)
- Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. (2014) (58)
- The intermediate hepatocellular carcinoma stage: Should treatment be expanded? (2010) (56)
- Use of VEGFR-2 Targeted Ultrasound Contrast Agent for the Early Evaluation of Response to Sorafenib in a Mouse Model of Hepatocellular Carcinoma (2015) (55)
- Experience with regorafenib in the treatment of hepatocellular carcinoma (2021) (55)
- Ultrasound in portal hypertension--part 1. (2011) (55)
- EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part V – EUS-Guided Therapeutic Interventions (short version) (2016) (55)
- Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study. (2017) (54)
- Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. (2013) (53)
- Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma (2001) (52)
- Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (2016) (52)
- The changing scenario of hepatocellular carcinoma in Italy: an update (2014) (51)
- Assessment of vascular patterns of small liver mass lesions: value and limitation of the different Doppler ultrasound modalities (2000) (51)
- Comparison between alcohol‐ and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome (2016) (50)
- Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib (2018) (50)
- Cellular localization of hepatic cytochrome 1B1 expression and its regulation by aromatic hydrocarbons and inflammatory cytokines. (1999) (49)
- Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure. (2015) (49)
- A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end‐stage liver disease system (2007) (47)
- Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic era. The views of a panel of worldwide international experts (2020) (47)
- Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors (2006) (46)
- An Introduction to the EFSUMB Guidelines on Interventional Ultrasound (INVUS) (2015) (46)
- Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. (2005) (46)
- In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair. (2003) (46)
- Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis (2019) (45)
- Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients. (2013) (45)
- Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma (2017) (44)
- The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series (2014) (44)
- Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. (2009) (44)
- Analysis of survival and objective response (OR) in patients with hepatocellular carcinoma in a phase III study of lenvatinib (REFLECT). (2019) (44)
- Contrast-enhanced ultrasound for liver imaging: recent advances. (2012) (42)
- Role of Contrast‐Enhanced Ultrasonography in Primary Hepatic Lymphoma (2010) (42)
- EFSUMB statement on medical student education in ultrasound [short version] (2016) (41)
- TACE performed in patients with a single nodule of Hepatocellular Carcinoma (2014) (40)
- Vascularity of liver tumours and recent advances in doppler ultrasound. (2001) (39)
- Superior mesenteric artery impedance in chronic liver diseases: relationship with disease severity and portal circulation (1998) (39)
- Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up. (2014) (39)
- A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis (2019) (39)
- Clinical trial: peg‐interferon alfa‐2b and ribavirin for the treatment of genotype‐1 hepatitis C recurrence after liver transplantation (2008) (39)
- Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study (2019) (38)
- Lenvatinib versus sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis (2021) (38)
- Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper. (2021) (37)
- An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. (2014) (37)
- Hepatorenal syndrome: Update on diagnosis and treatment. (2015) (37)
- Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices (2000) (36)
- Molecular Adsorbent Recirculating System (MARS) Application in Liver Failure: Clinical and Hemodepurative Results in 22 Patients (2006) (35)
- A benign tumour of the liver mimicking malignant liver disease – cholangiocellular adenoma (2009) (34)
- Contrast Enhanced Ultrasound in Pediatric Patients: A Real Challenge (2014) (34)
- EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part IV – EUS-guided interventions: General Aspects and EUS-guided Sampling (Short Version) (2016) (33)
- A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease (2017) (33)
- The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib (2020) (33)
- Mars and Prometheus: our clinical experience in acute chronic liver failure. (2008) (32)
- Influence of liver fibrosis on hepatic artery Doppler resistance index in chronic hepatitis of viral origin. (2001) (32)
- MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma (2020) (32)
- Relationship between splanchnic, peripheral and cardiac haemodynamics in liver cirrhosis of different degrees of severity (1997) (31)
- Treatment of hepatocellular carcinoma in Child-Pugh B patients. (2013) (31)
- Influence of the Spleen on Portal Haemodynamics: a Non-invasive Study with Doppler Ultrasound in Chronic Liver Disease and Haematological Disorders (2002) (31)
- Real-time contrast-enhanced ultrasound--a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax. (2008) (30)
- Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma (2013) (30)
- Association between overall survival and adverse events with lenvatinib treatment in patients with hepatocellular carcinoma (REFLECT). (2019) (30)
- Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases (2013) (30)
- Small (≤3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT (2009) (29)
- Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) (2021) (29)
- Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study. (2008) (29)
- Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database (2021) (28)
- Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma (2015) (28)
- TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma (2021) (27)
- Expression of ECM proteins fibulin-1 and -2 in acute and chronic liver disease and in cultured rat liver cells (2009) (27)
- Diagnosis and management of hepatic focal nodular hyperplasia. (2007) (27)
- European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Policy Document Development Strategy – Clinical Practice Guidelines, Position Statements and Technological Reviews (2018) (26)
- Treatment of Combined Hepatocellular and Cholangiocarcinoma (2020) (25)
- Liver transplantation for HCC. Treatment options on the waiting list (2003) (25)
- Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective? (2015) (25)
- Years of life that could be saved from prevention of hepatocellular carcinoma (2016) (25)
- Guidelines, Clinical Practice Recommendations, Position Papers and Consensus Statements: Definition, Preparation, Role and Application (2014) (25)
- Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis C after transplantation (2010) (24)
- Final analysis of serum biomarkers in patients (pts) from the phase III study of lenvatinib (LEN) vs sorafenib (SOR) in unresectable hepatocellular carcinoma (uHCC) [REFLECT]. (2018) (24)
- Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness (2017) (23)
- 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta‐analysis (2020) (23)
- MicroRNAs in Animal Models of HCC (2019) (23)
- Quantification of enhancement of focal liver lesions during contrast-enhanced ultrasound (CEUS). Analysis of ten selected frames is more simple but as reliable as the analysis of the entire loop for most parameters. (2012) (22)
- Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study (2021) (22)
- Detection of HCV antigens in liver graft: Relevance to the management of recurrent post‐liver transplant hepatitis C (2006) (21)
- Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis. (1999) (21)
- Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end‐stage cirrhosis (2007) (21)
- Bidimensional shear wave ultrasound elastography with supersonic imaging to predict presence of oesophageal varices in cirrhosis (2017) (21)
- Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate-advanced hepatocellular carcinoma. (2015) (21)
- Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma (2017) (21)
- EUS Needle Identification Comparison and Evaluation study (with videos). (2016) (20)
- Malignancies in primary biliary cirrhosis (2008) (20)
- Imaging Diagnosis of Hepatocellular Carcinoma: Recent Advances of Contrast-Enhanced Ultrasonography with SonoVue® (2015) (20)
- Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019. (2019) (20)
- Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma (2021) (20)
- Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. (2010) (20)
- Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy (2021) (20)
- Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging (2015) (20)
- Erratum: EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) : (Ultraschall in der Medizin (Stuttgart, Germany : 1980) (2017) 38 4 (e16-e47)) (2017) (19)
- Circadian occurrence of variceal bleeding in patients with liver cirrhosis (1996) (19)
- Sonographic assessment of the distal end of the thoracic duct in healthy volunteers and in patients with portal hypertension. (1995) (19)
- Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma (2019) (19)
- Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? (2009) (19)
- Recent advances in the diagnosis of hepatocellular carcinoma (2007) (19)
- Hemodynamics in focal nodular hyperplasia. (1999) (18)
- Review article: percutaneous treatment of hepatocellular carcinoma. (2003) (18)
- Caution in the use of boldo in herbal laxatives: A case of hepatotoxicity (2005) (18)
- Percutaneous treatment of hepatocellular carcinoma (2003) (17)
- Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria (2019) (17)
- Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib (2021) (17)
- Diagnosis of Hepatocellular Carcinoma with Non-Invasive Imaging: a Plea for Worldwide Adoption of Standard and Precise Terminology for Describing Enhancement Criteria (2017) (16)
- CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis. (2021) (16)
- LBA30Analysis of serum biomarkers (BM) in patients (pts) from a phase 3 study of lenvatinib (LEN) vs sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC) (2017) (16)
- Efficacy and Safety of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III Trials (2017) (16)
- Influence of esophageal varices and spontaneous portal-systemic shunts on postprandial splanchnic hemodynamics (2001) (16)
- Knowledge of the bio-effects of ultrasound among physicians performing clinical ultrasonography: Results of a survey conducted by the Italian Society for Ultrasound in Medicine and Biology (SIUMB). (2009) (15)
- The importance of liver functional reserve in the non-surgical treatment of Hepatocellular Carcinoma. (2021) (15)
- Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications (2021) (15)
- Peptic ulcer in patients with liver cirrhosis: a retrospective endoscopic and clinical study. (1997) (15)
- Left ventricular volumes in liver cirrhosis. (2000) (15)
- Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis (2022) (15)
- Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (2019) (15)
- Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions (2021) (14)
- Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib (2021) (14)
- Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis. (2006) (13)
- Liver cirrhosis, ascites, and hyperfibrinolysis (2001) (13)
- Duplex Doppler findings in splenic arteriovenous fistula (1998) (13)
- Role of real-time contrast-enhanced ultrasound in the assessment of metastatic portal vein thrombosis. (2007) (13)
- Utility‐based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha‐fetoprotein model as a survival predictor (2015) (12)
- Management of small hepatocellular carcinoma. (2006) (12)
- A new horizon in the prevention of the postembolization syndrome after transcatheter arterial chemoembolization for hepatocellular carcinoma (2018) (12)
- Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC (2021) (12)
- Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma (2020) (11)
- Adverse events as potential predictive factors of activity in advanced hepatocellular carcinoma patients treated with lenvatinib. (2021) (11)
- Liver metastases from rectal carcinoma: Disease progression during chemotherapy despite loss of arterial‐phase hypervascularity on real‐time contrast‐enhanced harmonic sonography at low acoustic energy (2003) (11)
- Different techniques for ultrasound liver elastography. (2019) (11)
- Erratum: EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part VI – Ultrasound-Guided Vascular Interventions (2015) (11)
- A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. (2011) (11)
- Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. (2007) (11)
- Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders (2021) (10)
- Outcomes from a program of home care attendance in very frail elderly subjects. (2007) (10)
- 109 CLINICAL VALIDATION OF A SUB-STAGING PROPOSAL OF PATIENTS WITH INTERMEDIATE HCC (BCLC-B) (2013) (10)
- The Perceived Ability of Gastroenterologists, Hepatologists and Surgeons Can Bias Medical Decision Making (2020) (10)
- Reader agreement and accuracy of ultrasound features for hepatic steatosis (2018) (10)
- Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma (2021) (10)
- Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US. (2020) (10)
- Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma (2018) (10)
- The chronically ill elderly patients discharged from the hospital: interim report from a controlled study of home care attendance. (2004) (10)
- Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis (2020) (10)
- Artificial Intelligence: What Is It and How Can It Expand the Ultrasound Potential in the Future? (2020) (10)
- Possible mechanisms for changes of intrasplenic arterial impedance indices in portal hypertension (1997) (10)
- Towards new tools for refined management of patients with advanced hepatocellular carcinoma under systemic therapy: some enthusiasm with a word of caution. (2013) (10)
- Echo-enhanced ultrasonography: is it the future gold standard of imaging in acute pancreatitis? (2005) (10)
- Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting (2021) (9)
- Contrast-Enhanced Ultrasound LI-RADS LR-5 in Hepatic Tuberculosis: Case Report and Literature Review of Imaging Features (2021) (9)
- Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma (2014) (9)
- Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (2020) (9)
- Ablation for hepatocellular carcinoma: beyond the standard indications (2020) (9)
- Doppler evaluation of the effects of pharmacological treatment of portal hypertension. (1999) (9)
- [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis]. (1997) (9)
- The application of artificial intelligence in hepatology: A systematic review. (2021) (8)
- Early Prediction of Treatment Response to Sorafenib with Elastosonography in a Mice Xenograft Model of Hepatocellular Carcinoma: A Proof-of-Concept Study (2013) (8)
- Fitz-Hugh-Curtis-syndrome mimicking acute cholecystitis: value of new ultrasound findings in the differential diagnosis. (2005) (8)
- Contrast-enhanced ultrasonography to diagnose complicated acute cholecystitis (2016) (8)
- Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs (2021) (8)
- Allelic Imbalance on 16q in Small, Unifocal Hepatocellular Carcinoma (2000) (7)
- Lenvatinib mesylate to treat hepatocellular carcinoma. (2019) (7)
- Ultrasound: the Only „One Stop Shop“ for Modern Management of Liver Disease (2013) (7)
- Contrast-enhanced harmonic endoscopic ultrasound-guided ethanol injection for a small hepatocellular carcinoma (2019) (7)
- MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma (2021) (7)
- CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodules (2017) (7)
- Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver. (2020) (7)
- Recent advances in the imaging of hepatocellular carcinoma. From ultrasound to positron emission tomography scan. (2007) (7)
- Ongoing challenges in the diagnosis of hepatocellular carcinoma (2016) (6)
- Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter (2021) (6)
- Hepatic artery thrombosis and graft ischemia in the presence of preserved arterial inflow: Not a contradiction but a real possibility (2004) (6)
- Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma (2018) (6)
- Contrast enhanced ultrasonography for the evaluation of coil embolization of splenic artery aneurysm. (2010) (6)
- Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT (2021) (6)
- Contrast-Enhanced Ultrasound: Development of Syllabus for Core Theoretical and Practical Competencies. (2020) (6)
- Intrahepatic artery pseudoaneurysm: A possible complication of blind thoracentesis (1999) (6)
- Widen NomoGram for multinomial logistic regression: an application to staging liver fibrosis in chronic hepatitis C patients (2017) (6)
- Hepatocellular carcinoma in non alcoholic fatty liver disease. (2020) (6)
- Cirrhosis does not shift the circadian phase of plasma fibrinolysis (2002) (6)
- Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice? (2009) (5)
- Cirrhosis does not shift the circadian phase of plasma fibrinolysis. (2002) (5)
- 265 COST-EFFECTIVENESS OF HEPATIC RESECTION VERSUS PERCUTANEOUS ABLATION FOR HEPATOCELLULAR CARCINOMA WITHIN THE MILAN CRITERIA (2013) (5)
- Nodule in nodule: malignant transformation of a macroregenerative nodule in cirrhosis revealed by duplex-Doppler. (1999) (5)
- Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison (2021) (5)
- Clinico-Pathological Classification (2005) (5)
- Phase IIa safety and efficacy of milciclib, a pan-cyclin dependent kinase inhibitor, in unresectable, sorafenib-refractory or -intolerant hepatocellular carcinoma patients. (2020) (5)
- Metronomic capecitabine in advanced patients with hepatocellular carcinoma (HCC): Preliminary results (2007) (4)
- Prediction of significant fibrosis in chronic hepatitis C patients by artificial neural network analysis of clinical factors (2007) (4)
- Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study. (2022) (4)
- Field practice studies on sorafenib: lessons in systemic treatment of hepatocellular carcinoma. (2013) (4)
- Diagnosis of Cirrhosis and Portal Hypertension (1998) (4)
- Yttrium 90 radioembolization: The horizon is changing for patients with intermediate and advanced hepatocellular carcinoma (2013) (4)
- DAAs for HCV and risk of hepatocellular carcinoma: current standpoint. (2018) (4)
- "Survival benefit": the final destination, with still a long way to go. (2010) (4)
- Comparative efficacy of cabozantinib and ramucirumab after sorafenib for patients with advanced hepatocellular carcinoma and AFP ≥ 400 ng/ml (2021) (4)
- 50th years anniversary of EFSUMB: Initial roots, maturation, and new shoots. (2022) (4)
- Imaging of Liver Tumors in Patients with Chronic Liver Disease (2014) (4)
- Natural history of nonalcoholic steatohepatitis–associated hepatocellular carcinoma (2016) (4)
- 614 SPLENIC STIFFNESS ASSESSED BY ARFI (ACOUSTIC RADIATION FORCE IMAGING) CORRELATES WITH PORTAL PRESSURE IN CIRRHOSIS (2012) (4)
- Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection (2013) (4)
- SIUMB recommendations for focal pancreatic lesions (2020) (4)
- Doppler Ultrasound in Portal Hypertension (1997) (4)
- What Future for Ultrasound in Medicine? (2018) (4)
- Non-enhanced MRI surveillance for HCC: A new tool for all, none or selected patients at risk? (2020) (4)
- 1070 THE VALUE OF ARFI ELASTOGRAPHY FOR FIBROSIS EVALUATION IN PATIENTS WITH CHRONIC HEPATITIS C IN COMPARISON WITH LIVER BIOPSY-AN INTERNATIONAL MULTICENTER STUDY (2012) (4)
- Direct antiviral agents for HCV infection and hepatocellular carcinoma: facts and FADs (2019) (4)
- Pocket ultrasound devices to perform EchoScopy (2013) (3)
- Cardiac abnormalities in Cirrhosis (2001) (3)
- Selecting patients with hepatocellular carcinoma for transplantation (2007) (3)
- Left ventricular function in liver cirrhosis. (1996) (3)
- Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments (2022) (3)
- Tocilizumab: From Rheumatic Diseases to Covid-19. (2021) (3)
- Use of perfusional angiosonography in liver transplantation and conservative management of post-transplant intra-hepatic pseudo-aneurysm (2004) (3)
- Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation (2007) (3)
- Onset of bronchiolitis obliterans organizing pneumonia in a liver transplant recipient under peg-interferon and ribavirin treatment (2008) (3)
- Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib (2021) (3)
- EFSUMB guidelines on the clinical use of elastography (2013) (3)
- MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis Predicts Sorafenib Resistance in Hepatocellular (3)
- Non-invasive measurement of HVPG using graph analysis of dynamic contrast-enhanced ultrasound: the CLEVER study (2018) (3)
- P0340 : Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): A multicenter case-control study (2015) (3)
- Lung Ultrasound Is Often, but Not Always, Normal in Healthy Subjects: Considerations for COVID-19 Pandemic (2021) (3)
- Choledochoscope-assisted percutaneous fibrin glue sealing of bile leak complicating transarterial chemoembolization of hepatocellular carcinoma after liver transplantation. (2011) (3)
- Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension. (2004) (3)
- What Ultrasound Operators Must Be Well Aware of in a World With Raising Burden of Non Alcoholic Fatty Liver Disease? (2019) (3)
- Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease (2022) (3)
- Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma (2021) (3)
- Hepatitis C-associated B-cell non-Hodgkin lymphomas: The emerging role of miRNA-26b (2013) (3)
- Contrast Enhanced Ultrasound: Liver Imaging Reporting and Data System (CEUS LI-RADS) (2017) (3)
- Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area (2022) (3)
- Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population. (2022) (3)
- Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature (2022) (3)
- Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib (2021) (3)
- Clinical Practice Guidance and Education in Ultrasound: Evidence and experience are two sides of one coin! (2022) (2)
- Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials (2021) (2)
- Contrast ultrasound LI-RADS LR-5 in Hepatic Tuberculosis: Case Report and Literature Review of Imaging Features (2020) (2)
- 135 Staging of hepatic fibrosis by liver elastometry (fibroscan) in recurrent HCV infection in liver transplant recipients (2006) (2)
- Effect of Levovist on splanchnic hemodynamics in cirrhotic patients. (2003) (2)
- Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5) (2022) (2)
- 999P Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma (2020) (2)
- Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria (Br J Surg 2011; 98: 1201–1208) (2011) (2)
- Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma q (2008) (2)
- Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study (2015) (2)
- OC-13 Radiofrequency ablation versus hepatic resection for early hepatocellular carcinoma: a cost-effectiveness perspective (2013) (2)
- Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival. (2021) (2)
- 968 IMPACT OF GADOXETIC ACID (GD-EOB-DTPA)-ENHANCED MAGNETIC RESONANCE ON THE NON-INVASIVE DIAGNOSIS OF SMALL HEPATOCELLULAR CARCINOMA (2011) (2)
- Reply to Anticoagulation for Portal Vein Thrombosis in Cirrhosis. (2019) (2)
- Safety and efficacy of lenvatinib by starting dose (8 mg or 12 mg) based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT. (2019) (2)
- 1072 ACOUSTIC RADIATION FORCE IMPULSE (ARFI) ELASTOGRAPHY FOR THE ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B AND C - AN INTERNATIONAL STUDY (2012) (2)
- Improved detectability of the hepatic arterial tree in liver transplantation by perfusional angiosonography. (2004) (2)
- Contrast‐Enhanced Ultrasound (CEUS) in the Evaluation of Hemoperitoneum in Patients With Cirrhosis (2020) (2)
- An Uncommon Focal Liver Lesion: Intrahepatic Splenosis. (2020) (2)
- COVID-19: Has the Liver Been Spared? (2023) (2)
- Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study. (2022) (2)
- Daily modifications of splanchnic hemodynamics (SH) in cirrhotics with different degree of variceal bleeding (VB) risk (1995) (2)
- Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (2019) (2)
- Contrast-enhanced ultrasound of the liver in colorectal cancer: A useful tool in the right patient. (2020) (2)
- Retrospective analysis of safety of ultrasound-guided percutaneous liver biopsy in the 21st century (2021) (1)
- Efficacy of a short course of lung ultrasound for primary care physicians in the assessment of COVID-19-positive patients. (2022) (1)
- Independent imaging review (IIR) results in a phase 3 trial of lenvatinib (LEN) versus sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC). (2018) (1)
- POST-MARKETING RETROSPECTIVE ANALYSIS ON THE SAFETY OF SONOVUE, A SECOND GENERATION ULTRASOUND CONTRAST AGENT, IN ABDOMINAL APPLICATIONS. REPORT FROM 23.188 PATIENTS STUDIED IN ITALY (2005) (1)
- SAT-484-CEUS pattern of hepatocellular carcinoma: Prognostic implication (2019) (1)
- Evaluation of efficacy of antiangiogenic treatment using US-based techniques in a murine model of hepatocellular carcinoma (HCC) under different treatment schedule (2013) (1)
- Moderate alcohol consumption is associated with risk of fibrosis in patients with non-alcoholic fatty liver disease (2020) (1)
- Peg-interferon alfa-2b and ribavirin for the treatment of genotype 1 hepatitis C recurrence after liver transplantation (2007) (1)
- TACE performed in patients with a single nodule of Hepatocellular Carcinoma (2014) (1)
- Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma. (2022) (1)
- Tu1024 Which Elastographic Method (Transient Elastography or ARFI) is More Useful for Liver Fibrosis Evaluation in Patients With Chronic Hepatitis C? - an International Multicenter Study (2012) (1)
- Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis? (2023) (1)
- OC-27 Diagnostic accuracy of different patterns of contrast enhanced ultrasound in characterization of new nodules in liver cirrhosis with and without history of previous hepatocellular carcinoma (2011) (1)
- A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival (2023) (1)
- Is the Strongest Level of Medical Evidence Always Required for Guidelines Recommendations? (2021) (1)
- Can hepatocellular carcinoma tumor grade and microscopic vascular invasion be predicted with an artificial neural network (2009) (1)
- Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma (2014) (1)
- Clinical predictors of response to sorafenib in patients with hepatocellular carcinoma. (2013) (1)
- Hepatic artery resistance in portal vein thrombosis. (1996) (1)
- Personalized sorafenib therapy for hepatocellular carcinoma (2013) (1)
- Perfusional angiosonography with a second generation ultrasound contrast agent in the characterization of small nodules in cirrhosis (2003) (1)
- OC-26 The emerging impact of HCC-NAFLD in Italy (2012) (1)
- 489 CLINICAL IMPACT AND BEHAVIOUR OF SERUM AUTOANTIBODIES IN ADULT LIVER TRANSPLANTATION (2010) (1)
- Ultrasound Elastography: General and Technical Overview (2018) (1)
- Su1803 Which Factors Influence the Accuracy of Liver Stiffness Measurements by Transient Elastography (TE) and by Acoustic Radiation Force Impulse (ARFI) Elastography for Liver Fibrosis Evaluation? - The Analysis of a Large International Cohort of Patients (2013) (1)
- 136 Artificial neural network is superior to meld in predicting mortality of patients with end-stage liver disease (2006) (1)
- Editorial: Cigarette smoking, abdominal blood flow and abdominal diseases (1996) (1)
- IMP 1211 Splanchnic and systemic hemodynamic response to meal in cirrhotics with different bleeding risk (1997) (1)
- Liver Imaging Reporting and Data System: Review of Pros and Cons (2021) (1)
- Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial (2022) (1)
- Pattern of progression of intrahepatic cholangiocarcinoma impacts on survival: Implications for second-line trials (2021) (1)
- Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear. (2019) (1)
- Correction to: Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness (2018) (1)
- The expanding potential of functional liver imaging: From research tools to clinical practice in oncology and internal medicine. (2020) (1)
- PRELIMINARY RESULTS OF METRONOMIC CAPECITABINE TREATMENT IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC). (2007) (1)
- Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study (2018) (1)
- The Value of Acoustic Radiation Force Impulse Elastography Fibrosis Evaluation in Patients with Chronic HCV Hepatitis: A Multicentric International Study (2011) (1)
- Is the Correlation of Liver Stiffness Assessed by Acoustic Radiation Force Impulse Elastography with Fibrosis Influenced by the Aminotransferases Level in Chronic HCV Hepatitis? A Multicentric International Study (2011) (1)
- OC-15 Clinical validation of a sub-staging proposal of patients with intermediate HCC (BCLC-B) (2013) (1)
- Corrigendum to "Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study" [Dig. Liver Dis. 49 (2017) 802-808]. (2018) (1)
- Focal nodular hyperplasia: new findings at Doppler ultrasonography. (2020) (1)
- Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis. (2023) (1)
- Cardiac abnormalities in cirrhosis. (2001) (1)
- Portal pressure and Doppler. (2003) (1)
- Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery. (2022) (1)
- Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study) (2020) (1)
- Microwave ablation in skilled hands. A treatment opportunity gaining room in the field of single HCC 3–5 cm (2022) (1)
- Contrast Enhanced Imaging Pattern of Central Scar in Focal Nodular Hyperplasia (2010) (1)
- Down‐staging of hepatocellular carcinoma prior to liver transplantation: The power of selection (2009) (1)
- Contents Vol. 33, 2015 (2015) (0)
- Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study (2019) (0)
- Indications for Liver Transplantation (2015) (0)
- Treatment type is an independent prognostic factor for patients with intermediate stage hepatocellular carcinoma (2014) (0)
- Preoperative predictors of recurrence beyond Milan criteria in hepatocellular carcinoma patients treated with frontline liver resection (2023) (0)
- 249 CHANGES IN TUMOR STIFFNESS FOR EARLY PREDICTION OF TUMOR RESPONSE TO SORAFENIB: A PROOF-OF-CONCEPT STUDY WITH ELASTOSONOGRAPHY IN AN ANIMAL MODEL OF HEPATOCELLULAR CARCINOMA (HCC) (2011) (0)
- 2 PS Collagenase-3 expression in liver tumors (2002) (0)
- P972 SINGLE HEPATOCELLULAR CARCINOMA: IS TACE A VALID OPTION? (2014) (0)
- P586 APPEARANCE OF COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA IN CIRRHOSIS AT CONTRAST ENHANCED IMAGING TECHNIQUES (2014) (0)
- CS.01.3 THE EMERGING IMPACT OF HCC-NAFLD IN ITALY (2012) (0)
- 928 WHICH ELASTOGRAPHIC METHOD (TRANSIENT ELASTOGRAPHY OR ARFI) IS BETTER CORRELATED WITH LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C - AN INTERNATIONAL MULTICENTER STUDY (2012) (0)
- Correction to: Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib. (2021) (0)
- Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (2020) (0)
- Point Shear Wave Ultrasound Elastography to quantify liver stiffness with Esaote MyLab Twice compared to 2D-Shear Wave Elastography with Supersonic Imaging (2016) (0)
- Perfusional angiosonography in the detection of hypervasculariy in small (<3cm) HCC in cirrhosis (2003) (0)
- Prognostic impact of sarcopenia on patients with advanced hepatocellular carcinoma treated with sorafenib (2022) (0)
- Appearance of combined hepatocellular cholangiocarcinoma in cirrhosis at contrast enhanced imaging techniques (2014) (0)
- Mortality prediction with transient elastography after liver transplantation for liver failure of various aetiologies (2014) (0)
- Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients (2023) (0)
- Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index (2023) (0)
- Pattern of enhancement timing in focal nodular hyperplasia (FNH) investigated by perfusional angiosonography (2003) (0)
- A novel simplified Child-Turcotte-Pugh score for prognostic assessment and therapeutic decision in patients with hepatocellular carcinoma (2014) (0)
- 659 Analysis of Efficacy Improvement of Repeated Tace for Hcc (2011) (0)
- Ultrasound in the Assessment of Tumor Response in the Age of Targeted and Immuno-Oncology Therapies. Back to the Future (2019) (0)
- Long Term Results of Conversion from Twice-Daily Tacrolimus (Prograf®) to Once-Daily Prolonged Release Tacrolimus (Advagraf®) in Stable Liver Transplant Recipients: University of Bologna Experience: 1330 (2012) (0)
- Letter to the Editor (2012) (0)
- Portal hypertension: Not a contraindication to hepatic resection (2009) (0)
- 254 SINGLE HEPATOCELLULAR CARCINOMA SMALLER THAN 2 cm: ARE PERCUTANEOUS ETHANOL INJECTION AND RADIOFREQUENCY ABLATION EQUALLY EFFECTIVE? (2013) (0)
- HEPATIC ARTERY RESISTANCE IN PORTAL VEIN THROMBOSIS. AUTHOR'S REPLY (1996) (0)
- 155 Prediction of significant fibrosis in HCV-infected liver transplant recipients by artificial neural network analysis of clinical factors (2006) (0)
- What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy (1998) (0)
- Author ' s response to reviews Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal Title : cancer (2007) (0)
- LEFT VENTRICULAR FUNCTION IN LIVER CIRRHOSIS. AUTHORS' REPLY (1996) (0)
- Focal Liver Lesions other than Hepatocellular Carcinoma in Cirrhosis: Diagnostic Challenges (2022) (0)
- Incidence of late HCC recurrence after resection remains higher than first HCC: Implications for patients management (2008) (0)
- OC-1 Prospective Italian multicenter field-practice study with sorafenib for advanced hepatocellular carcinoma (2011) (0)
- 402 INCIDENCE OF LATE (<2 YEARS) HCC RECURRENCE AFTER SURGICAL RESECTION REMAINS HIGHER THAN OF FIRST HCC IN CIRRHOSIS: IMPLICATIONS FOR PATIENTS MANAGEMENT (2008) (0)
- Percutaneous radio-frequency ablation of small HCC: Factors related to clinical outcome and recurrence of disease (2008) (0)
- IMO 1228 Superior mesenteric artery Doppler impedance indexes in chronic liver diseases (1997) (0)
- Surveillance improves survival of intrahepatic cholangiocarcinoma arisen in liver cirrhosis (2020) (0)
- Benign Liver Lesions. Clinico-pathologica classification. (2005) (0)
- Prognostic impact of previous intraarterial treatment in patients with hcc treated with sorafenib (2023) (0)
- Aberrant FHIT transcripts in hepatocellular carcinoma and liver cirrhosis (1998) (0)
- CEUS LI-RADS and quantification software: evaluation of intra-operator, inter-operator, and software-operator agreement in classifying liver nodules into LI-RADS classes (2022) (0)
- 107 LIVER RESECTION AND RADIOFREQUENCY ABLATION IN THE TREATMENT OF SINGLE SMALL (≤3 CM) HEPATOCELLULAR CARCINOMA (HCC): LONG TERM EFFECTIVENESS IN A MULTICENTER SERIES (2012) (0)
- The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time (2022) (0)
- F-26 Changes in tumor stiffness for early prediction of tumor response to sorafenib: a proof-of-concept study with elastosonography in an animal model of hepatocellular carcinoma (HCC) (2011) (0)
- 1015 THE CHALLENGE OF TREATING HCC IN CHILD-PUGH B: NEED FOR SUBCLASSIFICATION (2011) (0)
- Feasibility of a focused ultrasound training course for medical undergraduate students (2013) (0)
- EFSUMB Course Book, 2nd Edition (2019) (0)
- F-56 Evaluation of efficacy of antiangiogenic treatment in a murine model of hepatocellular carcinoma under different treatment schedules (2013) (0)
- Long-Term Treatment With Natural Alpha-IFN in Hepatitis C Recurrence After OLT (2011) (0)
- Perfusion analysis with dynamic contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma: A pilot study of a novel parameter aiming to improve the detection of wash-out (2021) (0)
- Ahead of print History of Ultrasound in Medicine from its birth to date (2022), on occasion of the 50 Years Anniversary of EFSUMB historical medical ultrasound (2022) (0)
- T-37 Mortality prediction with transient elastography in recurrent-HCV infection after liver transplantation (2013) (0)
- Taxanes Hypersensitivity is not a risk factor for severe reactions to SARS-Cov-2 Vaccines. (2022) (0)
- Perirenal Ultrasound Abnormality: When to Think about Xanthogranulomatous Erdheim-Chester Disease (2022) (0)
- Assessment of long-term prognosis at detection of early hepatocellular carcinoma remains unsolved. (2014) (0)
- Splanchnic arterial doppler parameters in portal hypertension (1999) (0)
- Epidemiological, virological and clinical profile of HBsAg positive individuals in Italian hospital settings: interim results of the HBV/HDV PITER cohort (2022) (0)
- Doppler US in portal hypertension (1993) (0)
- Liver Fat Quantification: When do We Need It? (2023) (0)
- Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs (2023) (0)
- Changes in liver function following real-world transarterial chemoembolization (TACE) in US patients (pts) with hepatocellular carcinoma (HCC): The LiverT study. (2018) (0)
- Use of perfusional angiosonography in liver transplantation and conservatve management of post‐transplant intra‐hepatie pseudo‐aneurysm (2004) (0)
- Incidence and risk factors of esophagogastric varices bleeding in cirrhotic patients with advanced hepatocellular carcinoma treated with lenvatinib (2023) (0)
- Prophylaxis of post-ERCP pancreatic complications with gabexate. (2007) (0)
- [227] CONTRAST ENHANCED ULTRASOUND WITH SONOVUE. A NEW TOOL TO DETECT PERITONEAL-PLEURAL COMMUNICATIONS IN CIRRHOTIC PLEURASCITES (2007) (0)
- SP477HEPATIC REGENERATION WITH COUPLED PLASMAFILTRATION AND ADSORPTION FOR LIVER EXTRACORPOREAL DETOXIFICATION (HERCOLE STUDY) (2018) (0)
- R OME , F EBRUARY 23 rd -26 th , 2011 (2011) (0)
- Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria (2019) (0)
- Phase I/II trial of continuous hepatic arterial infusion (HAI) of Irinotecan in patients with hepatocellular carcinoma (HCC). Preliminary results. (2006) (0)
- 67P Real-world data for atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma (2022) (0)
- Correction to: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (The American Journal of Gastroenterology, (2016), 111, 1, (70-77), 10.1038/ajg.2015.389) (2018) (0)
- T-17 Impact of Gadoxetic acid (Gd-EOB-DTPA)-enhanced MR on the non-invasive diagnosis of small hepatocellular carcinoma (2011) (0)
- Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (2018) (0)
- Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients. (2023) (0)
- S1009 Long-Term Treatment with Alfa-IFN in Hepatitits C Recurrence After OLT (2009) (0)
- Expression of the ECM proteins fibulin-1 and -2 in acute and chronic liver disease and in cultured rat liver cells (2009) (0)
- Validation of a new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma in a European cohort (2015) (0)
- Doppler tissue characterization of small hepatic tumors. Comparison between doppler spectral analysis and color-power doppler flow imaging (1998) (0)
- Survival of patients with hepatocellular carcinoma (HCC) within the Bologna Liver Oncology Group: comparison with international guidelines (2015) (0)
- Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up! (2023) (0)
- Ultrasound-measured visceral adipose tissue correlates with risk factors, severity and co-morbidities of NAFLD better than waist circumference (2017) (0)
- 417 VIRTUAL TOUCH ASSESSMENT OF LIVER STIFFNESS IN CHRONIC LIVER DISEASE: COMPARISON WITH TRANSIENT ELASTOGRAPHY (2010) (0)
- Long-term treatment with α-IFN in hepatitits C recurrence after OLT (2009) (0)
- Acute and chronic deterioration in liver function after transarterial radioembolization (TARE) in US patients (pts) with hepatocellular carcinoma (HCC). (2018) (0)
- Perfusional pattern analysis of contrast enhanced ultrasound (CEUS) improves diagnostic accuracy and reproducibility (2009) (0)
- Extension of Bulevirtide monotherapy to 72 weeks in HDV patients with compensated cirrhosis: Efficacy and safety from the italian multicenter study (HEP4Di) (2023) (0)
- Characterization of small nodules in liver cirrhosis. The assessment of the vascular pattern at imaging techniques. The problem of "hypovascular" HCC (2004) (0)
- IMAGES IN HEPATOLOGY (1999) (0)
- 709 FACTORS INFLUENCING THE ACCURACY OF LIVER STIFFNESS MEASUREMENTS BY TRANSIENT ELASTOGRAPHY (TE) AND BY ACOUSTIC RADIATION FORCE IMPULSE (ARFI) ELASTOGRAPHY FOR LIVER FIBROSIS EVALUATION (2013) (0)
- Liver transplantation restores systemic and regional circulatory alterations of cirrhosis after a 24 months long follow-up (1998) (0)
- Loss of Heterozygosity of the Long Arm of Chromosome 16 in Hepatocellular Carcinoma on Liver Cirrhosis (1996) (0)
- F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA (2010) (0)
- Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value (2022) (0)
- Volume 12 - Issue 4, 2012 - CEUS in Non-Hepatic Applications EFSUMB Recommendations on Contrast Enhanced Ultrasound (CEUS) Non-Hepatic Applications (2017) (0)
- Letter to the Editor Regarding the Article “Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Hepatocellular Carcinoma: Diagnostic Performance and Interobserver Agreement” by Zhou and Collaborators (2022) (0)
- Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation (2007) (0)
- P965 PERSONALIZED THERAPY WITH SORAFENIB FOR HEPATOCELLULAR CARCINOMA (2014) (0)
- P0143 : Impulsional, point and bidimensional shear wave elastometry for portal hypertension: same stiffness thresholds? (2015) (0)
- Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (2019) (0)
- T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA (2010) (0)
- Ultrasound, the handyman serving our whole populations in the post COVID-19 pandemic (2021) (0)
- Contrast enhanced ultrasound in diagnosis of hepatocellular carcinoma (HCC): role of wash-out in portal and late phases (2008) (0)
- T-23 Splenic stiffness assessed by ARFI (acoustic radiation force impulse) correlates with portal pressure in liver cirrhosis (2012) (0)
- Effects of SARS-CoV2 pandemic in a cohort of italian NAFLD patients (2022) (0)
- Spleen and Liver Fibrosis Is Associated to Treatment Response and Prognosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms (2021) (0)
- F.N.26 Efficacy of Superselective Tace in Treatment of Hcc (2010) (0)
- CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis. (2023) (0)
- Contents Vol. 7, 2018 (2018) (0)
- AGT gene polymorphisms predict early dose modification of sorafenib for dermatological adverse events: towards tailored medicine for patients with hepatocellular carcinoma (2019) (0)
- Cellular localization and regulation of cytochrome P450-1B1 in different liver cell populations (1998) (0)
- 1001 RAPID, MARKED WASH OUT AT CONTRAST ENHANCED ULTRASOUND IN NODULES IN CIRRHOSIS SHOULD RAISE THE SUSPICION OF CHOLANGIOCARCINOMA (2011) (0)
- Impulsional, point and bidimensional share wave elastometry for portal hypertension: same stiffness threshold? (2015) (0)
- Reply to: "non-invasive diagnosis of small nodules in cirrhosis". (2013) (0)
- 79 INFLUENCE OF AMINOTRANSFERASES LEVEL ON THE CORRELATION OF LIVER STIFFNESS ASSESSED BY ACOUSTIC RADIATION FORCE IMPULSE (ARFI) ELASTOGRAPHY WITH LIVER FIBROSIS-AN INTERNATIONAL MULTICENTER STUDY (2012) (0)
- SAT-475-Clinical validation of the role of contrast-enhanced ultrasound in the EASL guidelines for the diagnosis of hepatocellular carcinoma (2019) (0)
- Different clinical patterns of hepatocellular carcinoma (HCC) in patients with NAFLD and HCV related chronic liver disease (2015) (0)
- 11 VIRTUAL TOUCH ASSESSMENT OF LIVER CIRRHOSIS IN CHRONIC LIVER DISEASE DURING CONVENTIONAL ULTRASOUND SCANNING (2010) (0)
- 1074 EVALUATION OF EFFICACY OF ANTIANGIOGENIC TREATMENT IN A MURINE MODEL OF HEPATOCELLULAR CARCINOMA UNDER DIFFERENT TREATMENT SCHEDULES (2013) (0)
- Comparison of Two Elastographic Methods (Transient Elastography and Acoustic Radiation Force Impulse Elastography) for Fibrosis Assessment in Patients with Chronic HCV Hepatitis (2011) (0)
- P450-1B1 expression and regulation in different liver cells (1998) (0)
- Venous Doppler findings are commonly detectable also in focal nodular hyperplasia with modern ultrasound equipments (2008) (0)
- Therapy with DAA increases post-OLT survival but not the risk of recurrence in patients undergoing liver transplantation for HCV-related HCC (2020) (0)
- P996 PROPOSAL FOR AN UPDATE OF THE BARCELONA STAGING SYSTEM FOR HEPATOCELLULAR CARCINOMA BASED ON THE ROLE OF PERFORMANCE STATUS (2014) (0)
- Contents Vol. 8, 2019 (2019) (0)
- A simple characterization of dynamic changes in circulating CD8+PD1+ lymphocytes early predicts response to atezolizumab-bevacizumab in hepatocellular carcinoma (2023) (0)
- 167 Detection of HCV antigens as a unique tool to identify hcv infection of liver graft: Relevance to the management of recurrent post liver transplant hepatitis C (2006) (0)
- Mortality prediction with transient elastography in recurrent-HCV infection after liver transplantation (2013) (0)
- [172] DETECTION OF HCV ANTIGENS IN EARLY POST-LIVER TRANSPLANT GRAFT BIOPSIES PREDICTS RECURRENT HEPATITIS C AFTER 1 YEAR IN PATIENTS TRANSPLANTED FOR HCV RELATED LIVER DISEASE (2007) (0)
- CMAR_A_330195 9379..9389 (2021) (0)
- Cost-effectiveness of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma (2009) (0)
- Front & Back Matter (2012) (0)
- THU-078 - Metabolic Disorders across Hepatocellular Carcinoma in Italy (2016) (0)
- Tu1022 Is the Correlation of Liver Stiffness Assessed by Acoustic Radiation Force Impulse Elastography (ARFI) Influenced by the Aminotransferases Level? - an International Multicenter Study (2012) (0)
- Liver stiffness fibrosis thresholds of Fibroscan cannot be adopted by all new elastography machines: A comparative study (2017) (0)
- T.08.10 IMPACT OF SARCOPENIA ON SURVIVAL OF PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB (2022) (0)
- Acknowledgement of Reviewers 2017 (2018) (0)
- Liver transplantation does not completely correct the haemostatic abnormalities of cirrhotic patients (2007) (0)
- Liver Transplantation from Deceased Donors (2014) (0)
- 811 COST-EFFECTIVENESS OF RECALL STRATEGIES FOR NON-INVASIVE DIAGNOSIS OF SMALL HEPATOCELLULAR CARCINOMA (2009) (0)
- F-16 Applicability of international guidelines in the therapeutic algorithm of hepatocellular carcinoma (2012) (0)
- PEG-interferon-induced allograft dysfunction in liver transplant recipients with hepatitis C recurrence: De novo autoimmune hepatitis? (2006) (0)
- 20 - EcoDoppler TSA (2017) (0)
- Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease (2023) (0)
- Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research (2022) (0)
- Risk factors for significant fibrosis differently affect patients with non-alcoholic liver disease depending on gender (2020) (0)
- Tissue characterization of small hepatic tumors. Quantitative doppler spectral analysis vs. power doppler flow imaging (1998) (0)
- P989 A NOVEL SIMPLIFIED CHILD–TURCOTTE–PUGH SCORE FOR PROGNOSTIC ASSESSMENT AND THERAPEUTIC DECISION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2014) (0)
- PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE IN HYPERTENSIVE PATIENTS: P1.45 (2000) (0)
- Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment. (2021) (0)
- T-40 Clinical and economic impact of the updated AASLD criteria for the diagnosis of hepatocellular carcinoma (HCC) (2013) (0)
- Prospective down-staging protocol for HCC not meeting the Milan criteria (2006) (0)
- Appearance and spontaneous regression of a urinoma in the absence of hydronephrosis during acute obstructive renal disease (1998) (0)
- MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma (2023) (0)
- Histological renal damage and eligibility for kidney donation are worse in patients with biopsy-proven non-alcoholic steatohepatitis compared with simple steatosis (2020) (0)
- A regret-based approach to choose between trans-catheter arterial embolization and hepatic resection for intermediate hepatocellular carcinoma (2014) (0)
- 17 OC Recurrence after percutaneous radio-frequency thermal ablation in previously treated and untreated hepatocellular carcinoma (2002) (0)
- PA.190 DAILY LONG TERM ALFA-IFN IN HCV RECURRENCE AFTER LIVER TRANSPLANTATION: RESULTS OF AN ONGOING STUDY (2008) (0)
- FRI-474-AGT gene polymorphisms predict early dose modification of sorafenib for dermatological adverse events: towards tailored medicine for patients with hepatocellular carcinoma (2019) (0)
- Validation of the prognostic role of a new distinct assessment of liver function in non surgical HCC patients (2022) (0)
- Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease (2018) (0)
- Impact of anticoagulation on the evolution of portal vein thrombosis in cirrhosis: a retrospective analysis (2015) (0)
- Characterization of tumor responses in patients (pts) with unresectable hepatocellular carcinoma (uHCC) treated with lenvatinib in REFLECT. (2022) (0)
- Development of a nomogram based on clinical factors for prediction of significant fibrosis in chronic hepatitis C patients (2009) (0)
- Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors (2007) (0)
- Ultrasound of liver transplantation (2020) (0)
- Survival and recurrences after curative treatments of HCV-related early hepatocellular carcinoma. A meta-analysis of single arm studies (2017) (0)
- Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma (2023) (0)
- Protective role of aspirin chronic assumption in patients treated with sorafenib for hepatocellular carcinoma (2020) (0)
- Gaining knowledge for the choice and use of systemic therapies in the treatment of hepatocellular carcinoma also requires real life and investigators conducted observational studies. (2022) (0)
- Diagnostic accuracy of liver and spleen stiffness measurement for portal hypertension using bidimensional shear weave elastography (2015) (0)
- Detection of HCV antigens in early post-liver transplant graft biopsies predicts recurrent hepatitis C after 1 year in patients transplanted for HCV related liver disease (2007) (0)
- Tu1023 Is Acoustic Radiation Force Impulse Elastography (ARFI) a Useful Method for Noninvasive Fibrosis Evaluation in Patients With Chronic Hepatitis C? - an International Multicenter Study (2012) (0)
- Changes in Tumor Stiffness for Early Prediction of Tumor Response to Sorafenib: A Proof-of-Concept Study with Elastosonography in an Animal Model of Hepatocellular Carcinoma (HCC) (2011) (0)
- Contents Vol. 32, 2014 (2014) (0)
- Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma: efficacy, safety and prognostic factors (2021) (0)
- FRI-475-Experience impacts on reasons leading to sorafenib discontinuation and chance of long-term response tyrosine-kinase inhibitors, as these molecules share a common toxicity-profile. (2019) (0)
- A Case of Antibiotic-Resistant Dorsal Hand Purulent Tenosynovitis Diagnosed by Ultrasound Post Liver Transplant (2009) (0)
- Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Fabio Piscaglia?
Fabio Piscaglia is affiliated with the following schools:
